Bionano Genomics报告第四季度业绩

2026-03-24 04:11

Bionano Genomics press release (BNGO): Q4 net loss of $8M.
Revenue of $8M (-2.4% Y/Y) beats by $0.12M.
Sold 7,554 nanochannel array flowcells in the fourth quarter of 2025, representing a decrease of 6% over the 8,058 flowcells sold in the fourth quarter of 2024.

Initiating Q1 2026 revenue guidance in the range of $6.5M to $6.7M vs consensus revenue of $7.15M.
Initiating full-year 2026 revenue guidance in the range of $30M to $33M vs consensus revenue of $34.55M.

More on Bionano Genomics